FCRL6 is an immunoregulator gene in cytotoxic T and NK cells, and the elevated level of this gene and its potential mechanistic role represented this gene as a favorable biomarker and therapeutic target in cancer (Davis, 2020). This evidence concerns the gene FCRL6 and cancer.